These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 193759)

  • 21. Hydrokinetic activity of secretion and secretin analogues, modified in the N-terminal sequence, and of vasoactive intestinal peptide in the dog pancreas.
    Lehnert P; Forell MM; Jaeger E; Moroder L; Wünsch E
    Digestion; 1981; 22(2):85-8. PubMed ID: 7274610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide.
    Christophe JP; Conlon TP; Gardner JD
    J Biol Chem; 1976 Aug; 251(15):4629-34. PubMed ID: 947900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors and cell activation associated with pancreatic enzyme secretion.
    Gardner JD; Jensen RT
    Annu Rev Physiol; 1986; 48():103-17. PubMed ID: 2423019
    [No Abstract]   [Full Text] [Related]  

  • 25. Peptide receptors in human lung tumor cells in culture: vasoactive intestinal peptide (VIP) and secretin interaction with the Calu-1 and SW-900 cell lines.
    Laburthe M; Boissard C; Chevalier G; Zweibaum A; Rosselin G
    Regul Pept; 1981 Aug; 2(4):219-30. PubMed ID: 6169119
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interaction of gastrointestinal hormones with pancreatic cells in the rat].
    Robberecht P; Deschodt-Lanckman M; De Neef P; Christophe J
    Arch Int Physiol Biochim; 1974 Feb; 82(1):196. PubMed ID: 4136391
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini.
    Jensen RT; Charlton CG; Adachi H; Jones SW; O'Donohue TL; Gardner JD
    Am J Physiol; 1983 Aug; 245(2):G186-95. PubMed ID: 6309017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for gastrointestinal hormones.
    Gardner JD
    Gastroenterology; 1979 Jan; 76(1):202-14. PubMed ID: 213350
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological aspects of secretin, substance P, and VIP.
    Yanaihara N; Sakagami M; Sato H; Yammamoto K; Hashimoto T
    Gastroenterology; 1977 Apr; 72(4 Pt.2):803-10. PubMed ID: 838240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig.
    Dupont C; Broyart JP; Broer Y; Chenut B; Laburthe M; Rosselin G
    J Clin Invest; 1981 Mar; 67(3):742-52. PubMed ID: 6259209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular action of gastrointestinal polypeptide hormones.
    Borsy J; Andrási F; Kósa E
    Acta Physiol Acad Sci Hung; 1976; 47(4):323-33. PubMed ID: 203165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analogs: correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells.
    Taparel D; Susini C; Esteve JP; Diaz J; Cazaubon C; Vaysse N; Ribet A
    Peptides; 1985; 6(1):109-14. PubMed ID: 2859571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrointestinal hormone receptors].
    Kaneko T
    Nihon Rinsho; 1981 Sep; 39(9):3020-6. PubMed ID: 6121924
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastrointestinal peptides: the basis of action at the cellular level.
    Gardner JD; Jensen RT
    Recent Prog Horm Res; 1983; 39():211-43. PubMed ID: 6195697
    [No Abstract]   [Full Text] [Related]  

  • 38. Receptor for secretagogues on pancreatic acinar cells.
    Gardner JD; Jensen RT
    Am J Physiol; 1980 Feb; 238(2):G63-6. PubMed ID: 6153868
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isolation of porcine vasoactive intestinal polypeptide and comparison of its biological activities with secretin and glucagon (author's transl)].
    Suzuki S; Araki K; Tachibana S
    Yakugaku Zasshi; 1979 Feb; 99(2):172-9. PubMed ID: 438947
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis, biological and immunochemical properties of analogues of secretin and vasoactive intestinal peptide (VIP): the vasectrins.
    Beyerman HC; Buijen van Weelderen AW; Chang TM; Chey WY; Grossman MI; Kranenburg P; Scratcherd T; Solomon TE; Voskamp D
    Life Sci; 1981 Aug; 29(9):895-902. PubMed ID: 7300581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.